Drug Profile
Research programme: antimicrobials - The Scripps Research Institute/OPKO Health
Latest Information Update: 28 Oct 2019
Price :
$50
*
At a glance
- Originator The Scripps Research Institute
- Developer OPKO Health; The Scripps Research Institute
- Class
- Mechanism of Action Bacterial protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 28 Oct 2019 No recent reports of development identified for research development in Bacterial-infections in USA
- 09 Sep 2015 Early research in Bacterial infections in USA (unspecified route)